Annual Long Term Debt
$1.69 M
-$90.70 M-98.17%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual long term debt is $1.69 million, with the most recent change of -$90.70 million (-98.17%) on December 31, 2023.
- During the last 3 years, AVDL annual long term debt has fallen by -$128.36 million (-98.70%).
- AVDL annual long term debt is now -98.83% below its all-time high of $144.10 million, reached on December 31, 2021.
Performance
AVDL Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$1.22 M
-$92.00 K-7.03%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly long term debt is $1.22 million, with the most recent change of -$92.00 thousand (-7.03%) on September 30, 2024.
- Over the past year, AVDL quarterly long term debt has dropped by -$474.00 thousand (-28.05%).
- AVDL quarterly long term debt is now -99.16% below its all-time high of $144.10 million, reached on December 31, 2021.
Performance
AVDL Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
AVDL Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.2% | -28.1% |
| 3 y3 years | -98.7% | +148.2% |
| 5 y5 years | -98.5% | +148.2% |
AVDL Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.8% | at low | -99.2% | +148.2% |
| 5 y | 5-year | -98.8% | at low | -99.2% | +148.2% |
| alltime | all time | -98.8% | +983.3% | -99.2% | +679.5% |
Avadel Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.22 M(-7.0%) |
| Jun 2024 | - | $1.31 M(-9.7%) |
| Mar 2024 | - | $1.45 M(-14.3%) |
| Dec 2023 | $1.69 M(-98.2%) | $1.69 M(-12.3%) |
| Sep 2023 | - | $1.93 M(+293.5%) |
| Jun 2023 | - | $490.00 K(-99.5%) |
| Mar 2023 | - | $93.78 M(+1.5%) |
| Dec 2022 | $92.39 M(-35.9%) | $92.39 M(-16.7%) |
| Sep 2022 | - | $110.96 M(+1.5%) |
| Jun 2022 | - | $109.34 M(-7.4%) |
| Mar 2022 | - | $118.03 M(-18.1%) |
| Dec 2021 | $144.10 M(+10.8%) | $144.10 M(+0.4%) |
| Sep 2021 | - | $143.55 M(+0.1%) |
| Jun 2021 | - | $143.36 M(+0.1%) |
| Mar 2021 | - | $143.18 M(+10.1%) |
| Dec 2020 | $130.05 M(+4.9%) | $130.05 M(+1.2%) |
| Sep 2020 | - | $128.49 M(+1.2%) |
| Jun 2020 | - | $126.97 M(+1.2%) |
| Mar 2020 | - | $125.46 M(+1.2%) |
| Dec 2019 | $124.00 M(+7.1%) | $124.00 M(+0.8%) |
| Sep 2019 | - | $123.00 M(+0.6%) |
| Jun 2019 | - | $122.25 M(+1.0%) |
| Mar 2019 | - | $121.07 M(+4.6%) |
| Dec 2018 | $115.73 M(>+9900.0%) | $115.73 M(+1.2%) |
| Sep 2018 | - | $114.38 M(+1.2%) |
| Jun 2018 | - | $113.04 M(+1.2%) |
| Mar 2018 | - | $111.72 M(>+9900.0%) |
| Dec 2017 | $156.00 K(-71.5%) | $156.00 K(-74.6%) |
| Sep 2017 | - | $614.00 K(+3.4%) |
| Jun 2017 | - | $594.00 K(+7.0%) |
| Mar 2017 | - | $555.00 K(+1.5%) |
| Dec 2016 | $547.00 K(-20.0%) | $547.00 K(-25.5%) |
| Sep 2016 | - | $734.00 K(-6.9%) |
| Jun 2016 | - | $788.00 K(+11.0%) |
| Mar 2016 | - | $710.00 K(+3.8%) |
| Dec 2015 | $684.00 K(-46.4%) | $684.00 K(-99.4%) |
| Jun 2015 | - | $111.88 M(+42.4%) |
| Mar 2015 | - | $78.55 M(+6051.4%) |
| Dec 2014 | $1.28 M(-98.1%) | $1.28 M(-98.1%) |
| Sep 2014 | - | $68.06 M(-2.0%) |
| Jun 2014 | - | $69.47 M(+22.5%) |
| Mar 2014 | - | $56.69 M(-14.5%) |
| Dec 2013 | $66.33 M(+98.3%) | $66.33 M(+1.2%) |
| Sep 2013 | - | $65.52 M(-16.1%) |
| Jun 2013 | - | $78.11 M(+53.4%) |
| Mar 2013 | - | $50.93 M(+52.2%) |
| Dec 2012 | $33.46 M | $33.46 M(-30.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $48.05 M(+0.1%) |
| Mar 2012 | - | $48.00 M(+2374.4%) |
| Dec 2011 | $1.94 M(+15.5%) | $1.94 M(-1.5%) |
| Sep 2011 | - | $1.97 M(+10.5%) |
| Jun 2011 | - | $1.78 M(-6.1%) |
| Mar 2011 | - | $1.90 M(+13.0%) |
| Dec 2010 | $1.68 M(-44.2%) | $1.68 M(-7.9%) |
| Sep 2010 | - | $1.82 M(-36.1%) |
| Jun 2010 | - | $2.85 M(+1.7%) |
| Mar 2010 | - | $2.81 M(-6.7%) |
| Dec 2009 | $3.01 M(+27.3%) | $3.01 M(+22.1%) |
| Sep 2009 | - | $2.46 M(+4.7%) |
| Jun 2009 | - | $2.35 M(+4.5%) |
| Mar 2009 | - | $2.25 M(-4.7%) |
| Dec 2008 | $2.37 M(-3.2%) | $2.37 M(-3.0%) |
| Sep 2008 | - | $2.44 M(-9.5%) |
| Jun 2008 | - | $2.69 M(+4.5%) |
| Mar 2008 | - | $2.58 M(+5.5%) |
| Dec 2007 | $2.44 M(-20.3%) | $2.44 M(-21.5%) |
| Sep 2007 | - | $3.11 M(+3.0%) |
| Jun 2007 | - | $3.02 M(-0.5%) |
| Mar 2007 | - | $3.04 M(-1.0%) |
| Dec 2006 | $3.07 M(+3.5%) | $3.07 M(+15.5%) |
| Sep 2006 | - | $2.65 M(-4.0%) |
| Jun 2006 | - | $2.77 M(-2.6%) |
| Mar 2006 | - | $2.84 M(-4.1%) |
| Dec 2005 | $2.96 M(+24.6%) | $2.96 M(-23.9%) |
| Sep 2005 | - | $3.89 M(+59.3%) |
| Jun 2005 | - | $2.44 M(-3.2%) |
| Mar 2005 | - | $2.52 M(+6.2%) |
| Dec 2004 | $2.38 M(+22.8%) | $2.38 M(+19.3%) |
| Sep 2004 | - | $1.99 M(0.0%) |
| Jun 2004 | - | $1.99 M(+14.7%) |
| Mar 2004 | - | $1.74 M(-10.2%) |
| Dec 2003 | $1.94 M(+25.7%) | $1.94 M(+22.0%) |
| Sep 2003 | - | $1.59 M(-0.6%) |
| Jun 2003 | - | $1.60 M(+2.3%) |
| Mar 2003 | - | $1.56 M(+1.4%) |
| Dec 2002 | $1.54 M(+68.3%) | $1.54 M(+12.2%) |
| Sep 2002 | - | $1.37 M(+50.1%) |
| Dec 2001 | $915.00 K(-42.0%) | $915.00 K(-42.0%) |
| Dec 2000 | $1.58 M(-24.9%) | $1.58 M(-24.9%) |
| Dec 1999 | $2.10 M(-28.1%) | $2.10 M(-28.1%) |
| Dec 1998 | $2.92 M(-2.6%) | $2.92 M(+0.8%) |
| Mar 1998 | - | $2.90 M(-3.3%) |
| Dec 1997 | $3.00 M(+76.5%) | $3.00 M(+76.5%) |
| Dec 1996 | $1.70 M | $1.70 M(-5.6%) |
| Mar 1996 | - | $1.80 M |
FAQ
- What is Avadel Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual long term debt year-on-year change?
- What is Avadel Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly long term debt year-on-year change?
What is Avadel Pharmaceuticals annual long term debt?
The current annual long term debt of AVDL is $1.69 M
What is the all time high annual long term debt for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual long term debt is $144.10 M
What is Avadel Pharmaceuticals annual long term debt year-on-year change?
Over the past year, AVDL annual long term debt has changed by -$90.70 M (-98.17%)
What is Avadel Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of AVDL is $1.22 M
What is the all time high quarterly long term debt for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly long term debt is $144.10 M
What is Avadel Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, AVDL quarterly long term debt has changed by -$474.00 K (-28.05%)